Biopharmaceutical Sector Weekly Update – April 29, 2024

Biopharmaceutical Sector

Stifel’s recent report, leveraging data from the DealForma database, highlights key trends in biopharma M&A, including a rise in high-value deals and significant activity in immunology and oncology sectors. Checkout the Stifel story

All of this by stage, disease indication, modality, target…

+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures